CN Patent

CN118496239A — 一种酰乙酯多环化合物及其药物组合物和用途

Assigned to Nanjing Cavendish Bio Engineering Technology Co Ltd · Expires 2024-08-16 · 2y expired

What this patent protects

本发明公开了一种酰乙酯多环化合物及其药物组合物和用途。所述的酰乙酯多环化合物如式I所示，其中X为S或Se，该化合物对于病毒感染的个体具有预防或治疗作用。

USPTO Abstract

本发明公开了一种酰乙酯多环化合物及其药物组合物和用途。所述的酰乙酯多环化合物如式I所示，其中X为S或Se，该化合物对于病毒感染的个体具有预防或治疗作用。

Drugs covered by this patent

Patent Metadata

Patent number
CN118496239A
Jurisdiction
CN
Classification
—
Expires
2024-08-16
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Cavendish Bio Engineering Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.